The cost-effectiveness of hepatitis A vaccination in patients with chronic hepatitis C

Hepatology

Volumn 31, Issue 4, 2000, Pages 834-839

  Myers, Robert P ^a   Gregor, James C ^a   Marotta, Paul J ^a,b  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b LONDON HEALTH SCIENCES CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS A VACCINE;

ARTICLE; COST EFFECTIVENESS ANALYSIS; DISEASE ASSOCIATION; DRUG COST; FATALITY; HEALTH CARE PLANNING; HEPATITIS A; HEPATITIS C; HUMAN; LIVER FAILURE; LIVER TRANSPLANTATION; MEDICAL DECISION MAKING; PRIORITY JOURNAL; VACCINATION;

EID: 0034069744     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/he.2000.5719     Document Type: Article

References (7)

1. Koff RS. Hepatitis A. Lancet 1998;341:1643-1649.
2. Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 1996;45:1-30.
3. National Institutes of Health Development Conference. Management of HCV. HEPATOLOGY 1997;26(Suppl):1S-156S.
4. Van Doorslaer E, Tormans G, Van Damme P. Cost-effectiveness analysis of vaccination against hepatitis A in travelers. J Med Virol 1994;44:463-469.
5. Koff RS. Clinical manifestations and diagnosis of hepatitis A virus infection. Vaccine 1992;10(Suppl):S15-S17.
6. Keeffe EB. Is hepatitis A more severe in patients with chronic hepatitis B and other chronic liver diseases? Am J Gastroenterol 1995;90:201-205.
7. Vento S, Garofano T, Renzini C, Cainelli F, Casali F, Ghironzi G, Ferraro T, et al. Acute liver failure associated with hepatitis A virus superinfection in patients with chronic hepatitis C. N Engl J Med 1998;338:286-290.